Radnostix recalls Sodium Iodide
- Recalling company
- Radnostix
- Product
- Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.
- Reason
- Presence of Particulate Matter: Due to production issues
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jan 26, 2026
- Reported
- Mar 11, 2026
- Distribution
- Nationwide in the USA and Puerto Rico
- Status
- Ongoing
- Quantity
- 16 units
- Lot / codes
- Batch I012626R-01, Exp 02/09/2026
- Company location
- Idaho Falls, ID
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0389-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0389-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.